IP Library Assignment 069274/0101
Patent Assignment
Reel/Frame 069274/0101

Release of Security Interest

Recorded: 2024-10-29 Pages: 41
Assignor
Assignee
DERMAVENT SCIENCES GMBH
VIADUKTSTRASSE 8, BASEL, 4051, SWITZERLAND
Covered Properties (33)
Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues
Patent: 7,321,050 →
Application: 10/893,863 →
Publication: US 2005/0059733
Topical Pharmaceutical Compositions
Application: 15/158,858 →
Publication: US 2016/0338973
Novel Method of Use
Application: 15/529,671 →
Publication: US 2017/0360719
Topical Pharmaceutical Compositions
Application: 15/807,682 →
Publication: US 2018/0064656
Process for Preparing Tapinarof
Application: 16/189,268 →
Publication: US 2019/0144367
Topical Pharmaceutical Compositions
Application: 16/229,080 →
Publication: US 2019/0192445
Topical Pharmaceutical Compositions
Application: 16/229,145 →
Publication: US 2019/0192446
Topical Pharmaceutical Compositions
Application: 16/255,121 →
Publication: US 2019/0151255
Topical Pharmaceutical Compositions
Application: 16/587,833 →
Publication: US 2020/0101027
Use of Tapinarof for the Treatment of Chronic Plaque Psoriasis
Application: 16/682,476 →
Publication: US 2020/0147000
Use of Tapinarof for the Treatment of Atopic Dermatitis
Application: 16/682,485 →
Publication: US 2020/0147001
Process for Preparing Tapinarof
Application: 16/849,346 →
Publication: US 2021/0024442
Process for Preparing Tapinarof
Application: 17/174,566 →
Publication: US 2021/0163388
Gel, Ointment, and Foam Formulations of Tapinarof and Methods of Use
Application: 17/533,885 →
Publication: US 2022/0160650
Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation Dermatitis
Application: 17/674,577 →
Publication: US 2022/0265572
Use of Tapinarof for the Treatment of Chronic Plaque Psoriasis
Application: 17/734,877 →
Publication: US 2023/0106782
Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation Dermatitis
Application: 17/820,692 →
Publication: US 2022/0395472
Connector Assembly
Application: 17/871,633 →
Publication: US 2023/0058140
Topical Pharmaceutical Compositions
Application: 18/002,511 →
Publication: US 2023/0225987
ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR IMBALANCE
Application: 18/050,888 →
Publication: US 2023/0124135
Topical Pharmaceutical Compositions
Application: 18/066,945 →
Publication: US 2023/0126208
Use of Tapinarof for the Treatment of Atopic Dermatitis
Application: 18/163,631 →
Publication: US 2023/0190673
Process for Preparing Tapinarof
Application: 18/164,309 →
Publication: US 2023/0174445
Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis
Application: 63/150,204 →
Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation Dermatitis
Application: 63/260,322 →
Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation Dermatitis
Application: 63/261,523 →
Remittive Effects of Tapinarof in the Treatment of Plaque Psoriasis, Atopic Dermatitis, or Radiation Dermatitis
Application: 63/266,535 →
TAPINAROF AND ANALOGS THEREOF FOR USE IN TREATING AhR MEDIATED DISEASES
Application: 63/373,926 →
ISOQUINOLINE COMPOUNDS AND THEIR USE IN TREATING AhR MEDIATED DISEASES
Application: 63/373,929 →
TAPINAROF AND ANALOGS THEREOF FOR USE IN TREATING AhR MEDIATED DISEASES
Application: 63/387,011 →
Method of Treating Atopic Dermatitis in Adolescent Patients
Application: 63/462,860 →
Methods of Treating Atopic Dermatitis Using Tapinarof
Application: 63/466,979 →
Methods of Treating Atopic Dermatitis Using Tapinarof
Application: 63/490,470 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 17, 2004
From: ZHU, JIANG; CHEN, GENHUI; WEBSTGER, JOHN M.; LI, JIANXIONG
To: WELICHEM BIOTECH INC.
Reel/Frame 015388/0938 →
Assignment of Assignor's Interest Feb 17, 2010
From: CHEN, GENHUI; WEBSTER, JOHN M.; LI, JIANXIONG; HU, KAJI
To: WELICHEM BIOTECH INC.
Reel/Frame 023951/0199 →
Assignment of Assignor's Interest Feb 17, 2010
From: CHEN, GENHUI; WEBSTER, JOHN M.; LI, JIANXIONG; HU, KAJI
To: WELICHEM BIOTECH INC.
Reel/Frame 023951/0183 →
Assignment of Assignor's Interest Feb 17, 2010
From: CHEN, GENHUI; WEBSTER, JOHN M.; LI, JIANXIONG; HU, KAJI
To: WELICHEM BIOTECH INC.
Reel/Frame 023949/0036 →
Assignment of Assignor's Interest Aug 20, 2012
From: WELICHEM BIOTECH INC.
To: GLAXO GROUP LIMITED
Reel/Frame 028811/0458 →
Assignment of Assignor's Interest May 24, 2016
From: BEDARD, MARY; DOHERTY, MICHAEL QUINN; LENN, JON D.; SANTOS, LEANDRO L.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 038699/0133 →
Assignment of Assignor's Interest May 25, 2017
From: COTE-SIERRA, JAVIER; SMITH, SUSAN H.; FREY, STEVEN M.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 042507/0297 →
Security Interest Aug 24, 2018
From: DERMAVANT SCIENCES GMBH
To: NOVAQUEST CO-INVESTMENT FUND VIII, L.P.
Reel/Frame 046697/0848 →
Assignment of Assignor's Interest Sep 6, 2018
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 047480/0575 →
Assignment of Assignor's Interest Sep 6, 2018
From: GLAXO GROUP LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 047028/0116 →
Assignment of Assignor's Interest Nov 26, 2018
From: JAIN, PIYUSH
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 047582/0117 →
Assignment of Assignor's Interest Nov 26, 2018
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 047622/0638 →
Assignment of Assignor's Interest Dec 21, 2018
From: BEDARD, MARY; DOHERTY, MICHAEL QUINN; LENN, JON D.; SANTOS, LEANDRO L.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 047841/0308 →
Assignment of Assignor's Interest Dec 21, 2018
From: JAIN, PIYUSH
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 047846/0577 →
Assignment of Assignor's Interest Dec 21, 2018
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 047978/0530 →
Assignment of Assignor's Interest Jan 31, 2019
From: ANDREWS, IAN PAUL; CALANDRA, NICHOLAS; DAVIS, TYLER ANDREW; SUDINI, RAVINDER REDDY
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 048198/0822 →
Assignment of Assignor's Interest Jan 31, 2019
From: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 048199/0257 →
Assignment of Assignor's Interest Mar 12, 2019
From: JAIN, PIYUSH; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 048574/0500 →
Assignment of Assignor's Interest Mar 12, 2019
From: GLAXO GROUP LIMITED; GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 048577/0304 →
Assignment of Assignor's Interest Mar 12, 2019
From: SONTI, SUJATHA D.; LENN, JON D.; SANTOS, LEANDRO L.; WHITEMAN, JUSTIN E.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 048574/0173 →
Intellectual Property Security Agreement May 24, 2019
From: DERMAVANT SCIENCES GMBH
To: HERCULES CAPITAL, INC., AS AGENT
Reel/Frame 049285/0377 →
Assignment of Assignor's Interest Jun 6, 2019
From: GLAXO GROUP LIMITED; GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
To: DERMAVANT SCIENCES GMBH
Reel/Frame 049408/0500 →
Assignment of Assignor's Interest Jun 6, 2019
From: BEDARD, MARY; DOHERTY, MICHAEL QUINN; LENN, JON D.; SANTOS, LEANDRO L.
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 049398/0064 →
Assignment of Assignor's Interest Jun 6, 2019
From: JAIN, PIYUSH; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 049398/0433 →
Assignment of Assignor's Interest Oct 2, 2019
From: JAIN, PIYUSH; GLAXOSMITHKLINE LLC; GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LIMITED
To: GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED
Reel/Frame 050603/0661 →